HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frédéric Peyrusson Selected Research

RX-P873

8/2015RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frédéric Peyrusson Research Topics

Disease

5Infections
01/2022 - 08/2015
1Bacterial Infections (Bacterial Infection)
01/2018
1Neoplasms (Cancer)
04/2011
1Carcinoma (Carcinomatosis)
04/2011

Drug/Important Bio-Agent (IBA)

3Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 02/2020
1gepotidacinIBA
01/2018
1Topoisomerase InhibitorsIBA
01/2018
1RX-P873IBA
08/2015
1Protein Synthesis InhibitorsIBA
08/2015
1Trastuzumab (Herceptin)FDA Link
04/2011
1Cetuximab (Erbitux)FDA Link
04/2011
1Therapeutic UsesIBA
04/2011

Therapy/Procedure

1Therapeutics
04/2011